Divisão de ações reversa da alimera science
7 Nov 2019 ATLANTA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and 14 Nov 2019 14, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: will effect the previously announced one-for-15 reverse stock split of its 5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management 14 Nov 2019 Information Regarding the Reverse Stock Split and CUSIP Number Change Alimera Sciences, Inc. (ALIM) will effect a one-for-fifteen (1-15)
5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
7 Nov 2019 ATLANTA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and 14 Nov 2019 14, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: will effect the previously announced one-for-15 reverse stock split of its 5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management 14 Nov 2019 Information Regarding the Reverse Stock Split and CUSIP Number Change Alimera Sciences, Inc. (ALIM) will effect a one-for-fifteen (1-15)
5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
7 Nov 2019 ATLANTA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and 14 Nov 2019 14, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: will effect the previously announced one-for-15 reverse stock split of its 5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
14 Nov 2019 14, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: will effect the previously announced one-for-15 reverse stock split of its
5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
7 Nov 2019 ATLANTA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and 14 Nov 2019 14, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: will effect the previously announced one-for-15 reverse stock split of its 5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
7 Nov 2019 ATLANTA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and 14 Nov 2019 14, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: will effect the previously announced one-for-15 reverse stock split of its 5 Sep 2019 Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management 14 Nov 2019 Information Regarding the Reverse Stock Split and CUSIP Number Change Alimera Sciences, Inc. (ALIM) will effect a one-for-fifteen (1-15)